These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 25839013)
21. [Analysis of treatment and prognosis of 59 cases of vulvar melanoma]. Yuan GW; Li XG; Li N; Yao HW; Wu LY Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):395-401. PubMed ID: 32842246 [No Abstract] [Full Text] [Related]
22. Prognostic Factors for Patients with Primary Gliosarcoma: A Single-Center Retrospective Study. Li C; Zhou W; Wang P; Ji P; Wang Y; Guo S; Zhai Y; Xu M; Wang L; Feng F; Liu J World Neurosurg; 2024 Aug; ():. PubMed ID: 39216722 [TBL] [Abstract][Full Text] [Related]
23. Local delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma. Bow H; Hwang LS; Schildhaus N; Xing J; Murray L; Salditch Q; Ye X; Zhang Y; Weingart J; Brem H; Tyler B J Neurosurg; 2014 Mar; 120(3):662-9. PubMed ID: 24359008 [TBL] [Abstract][Full Text] [Related]
24. Gliosarcoma: an audit from a single institution in India of 24 post-irradiated cases over 15 years. Kumar P; Singh S; Kumar P; Krishnani N; Datta NR J Cancer Res Ther; 2008; 4(4):164-8. PubMed ID: 19052388 [TBL] [Abstract][Full Text] [Related]
25. Role of adjuvant radiation in the management of central neurocytoma: Experience from a tertiary cancer care center of India. Mallick S; Roy S; Das S; Joshi NP; Roshan V; Gandhi AK; Jana M; Julka PK; Rath GK Indian J Cancer; 2015; 52(4):590-7. PubMed ID: 26960488 [TBL] [Abstract][Full Text] [Related]
26. Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database. Frandsen J; Orton A; Jensen R; Colman H; Cohen AL; Tward J; Shrieve DC; Suneja G J Neurosurg; 2018 Apr; 128(4):1133-1138. PubMed ID: 28621623 [TBL] [Abstract][Full Text] [Related]
27. Adjuvant Radiation Therapy and Temozolomide in Gliosarcoma: Is It Enough? Case Series of Seven Patients. Srivastava H; Dewan A; Sharma SK; Negi P; Dewan AK; Pasricha S; Mehrotra K Asian J Neurosurg; 2018; 13(2):297-301. PubMed ID: 29682024 [TBL] [Abstract][Full Text] [Related]
28. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience. Jeon HJ; Kong DS; Park KB; Lee JI; Park K; Kim JH; Kim ST; Lim DH; Kim WS; Nam DH Clin Neurol Neurosurg; 2009 Oct; 111(8):679-82. PubMed ID: 19640635 [TBL] [Abstract][Full Text] [Related]
29. Retrospective comparison of standard and escalated doses of radiotherapy in newly diagnosed glioblastoma patients treated with concurrent and adjuvant temozolomide. Guler OC; Yıldırım BA; Önal C; Topkan E Indian J Cancer; 2019; 56(1):59-64. PubMed ID: 30950447 [TBL] [Abstract][Full Text] [Related]
30. Post-operative management of primary glioblastoma multiforme in patients over 60 years of age. Daróczi B; Szántó E; Tóth J; Barzó P; Bognár L; Bakó G; Szántó J; Mózes P; Hideghéty K Ideggyogy Sz; 2013 Nov; 66(11-12):391-8. PubMed ID: 24555238 [TBL] [Abstract][Full Text] [Related]
31. Gliosarcoma in septuagenarians and octogenarians: What is the impact of adjuvant chemoradiation? Shin JY; Yoon JK; Diaz AZ J Clin Neurosci; 2017 Nov; 45():77-82. PubMed ID: 28756069 [TBL] [Abstract][Full Text] [Related]
32. Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation. Videtic GM; Truong PT; Dar AR; Yu EW; Stitt LW Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):709-16. PubMed ID: 14529775 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience. Zhong L; Chen L; Lv S; Li Q; Chen G; Luo W; Zhou P; Li G Radiat Oncol; 2019 Jun; 14(1):104. PubMed ID: 31196126 [TBL] [Abstract][Full Text] [Related]
34. A study of clinico-pathological parameters and O⁶-methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma. Singh G; Mallick S; Sharma V; Joshi N; Purkait S; Jha P; Sharma MC; Suri V; Julka PK; Mahapatra AK; Singh M; Kale SS; Sarkar C Neuropathology; 2012 Oct; 32(5):534-42. PubMed ID: 22380407 [TBL] [Abstract][Full Text] [Related]
35. Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma. Perry JR; Laperriere N; O'Callaghan CJ; Brandes AA; Menten J; Phillips C; Fay M; Nishikawa R; Cairncross JG; Roa W; Osoba D; Rossiter JP; Sahgal A; Hirte H; Laigle-Donadey F; Franceschi E; Chinot O; Golfinopoulos V; Fariselli L; Wick A; Feuvret L; Back M; Tills M; Winch C; Baumert BG; Wick W; Ding K; Mason WP; N Engl J Med; 2017 Mar; 376(11):1027-1037. PubMed ID: 28296618 [TBL] [Abstract][Full Text] [Related]
36. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors. Piroth MD; Gagel B; Pinkawa M; Stanzel S; Asadpour B; Eble MJ Strahlenther Onkol; 2007 Dec; 183(12):695-702. PubMed ID: 18040615 [TBL] [Abstract][Full Text] [Related]
37. Secondary gliosarcoma: a review of clinical features and pathological diagnosis. Han SJ; Yang I; Tihan T; Chang SM; Parsa AT J Neurosurg; 2010 Jan; 112(1):26-32. PubMed ID: 19408981 [TBL] [Abstract][Full Text] [Related]
38. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry. Sreenan JJ; Prayson RA Arch Pathol Lab Med; 1997 Feb; 121(2):129-33. PubMed ID: 9126039 [TBL] [Abstract][Full Text] [Related]
39. Clinicopathological and Neuroimaging Features of Primary Gliosarcoma: A Case Series and Review of Literature. Matute-González M; Mosteiro-Cadaval A; Vidal-Robau N; Páez-Carpio A; Valduvieco I; Pineda E; González JJ; Aldecoa I; Oleaga L World Neurosurg; 2023 Oct; 178():e480-e488. PubMed ID: 37516148 [TBL] [Abstract][Full Text] [Related]
40. Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors. Mallick S; Gandhi AK; Joshi NP; Kumar A; Puri T; Sharma DN; Haresh KP; Gupta S; Julka PK; Rath GK; Sarkar C Indian J Med Paediatr Oncol; 2015; 36(2):99-104. PubMed ID: 26157286 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]